Results

Total Results: 1,055 records

Showing results for "diseases".

181. Availability of Outpatient Maternal Fetal Medicine and Specialty Care for Women with High-Risk Pregnancies (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-fullreport.pdf
     January 01, 2019 - disease specialist during their pregnancy … disease, HIV, diabetes, mental disorders, epilepsy, infectious diseases, placenta previa), increasing … and chronic illnesses is rising among women, and these diseases and illnesses increase women’s risk … The causes of pregnancy-related deaths in the United States are as follows: cardiovascular diseases … Congenital heart diseases require multidisciplinary care for early intervention and close monitoring

182. 3P_RD_AHRQ_PUF_Data_Dictionary (xls file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/data/3P-RD-Data-Dictionary.xlsx
     March 16, 2023 - secondary specialty in the CORE file Medical specialties include: Allergy/Immunology; Cardiovascular Disease … ; Nephrology; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology … Medical specialties include: Allergy/Immunology; Cardiovascular Disease (Cardiology); Interventional … Cardiology; Dermatology; Gastroenterology; Neurology; Cardiac Electrophysiology; Pulmonary Disease; Nephrology … ; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology/Oncology

183. Articulate Word Output (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/primary-prevention-cvd-with-statins.pdf
     May 10, 2018 - Articulate Word Output Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 1 … Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 2 Welcome by Michael … ll provide a discussion and update on the use of statins for primary prevention of cardiovascular disease … He’s concerned about heart disease and stroke and wants to know whether he should take a cholesterol … Patients with end-stage renal disease do not appear to benefit from statins.

184. New Study Shows Reductions in Antibiotic Use at Ambulatory Care Clinics Participating in HHS-funded Program | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/news/newsroom/press-releases/antibiotic-prescribing.html
     July 01, 2022 - Antibiotic medications have drastically reduced illness and death due to bacterial infectious diseases … Chicago, and AHRQ with input from a Technical Expert Panel including representatives from the Centers for Disease

185. CAHPS Health Literacy Item Sets | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/cahps/surveys-guidance/item-sets/literacy/index.html
     December 01, 2022 - following five topic areas: Communication with providers Communication about self-management of diseases … Universal Precautions Toolkit , AHRQ National Action Plan to Improve Health Literacy , Office of Disease

186. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
     February 12, 2018 - percentile for age in the absence of external vagal stimulus, β-blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

187. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
     February 09, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven

188. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
     April 26, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

189. Evidence Now Fact Sheets- Smoking Cessation (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/smoking-cessation-pcor.pdf
     November 01, 2016 - smoking accounts for one out of every five deaths and is estimated to increase the risk for heart disease … Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, et al, Centers for Disease Control and Prevention … Department of Health and Human Services, Centers for Disease Control and Prevention, National Center … for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. http://www.surgeongeneral.gov

190. Section 6, Tables 5 and 6 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-section-6-tables-5-6.pdf
     February 26, 2018 - Section 6, Tables 5 and 6 Table 5: Agreement and Kappa Statistics for Sickle Cell Disease for Inter‐Rater … Criterion 29 90% 0.79 Table 6: Appropriate Fever Management in the ED for Children with Sickle Cell Disease

191. Transforming Primary Care: Evaluating the Spread of Group Health's Medical Home (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/tpc/tpc-profile-reid.pdf
     April 01, 2015 - including after-hours nurse consultations and increased virtual visits via secure messaging), chronic disease … Only one process change module did not meet the implementation target—chronic disease management, the … module—which involved the creation of collaborative care plans for patients with selected chronic diseases

192. Evidence for Advancing Heart Health | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/evidencenow/projects/heart-health/evidence/index.html
     March 01, 2021 - Tools for Change Evidence for Advancing Heart Health Heart disease … attacks, health care professionals can work with their patients to adopt the ABCS of cardiovascular disease … Cholesterol management Smoking cessation Clinical evidence about how best to prevent cardiovascular disease

193. America's Health Literacy: Why We Need Accessible Health Information (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/health-literacy/dhhs-2008-issue-brief.pdf
     January 01, 2008 - Limited health literacy isn’t a disease that makes itself easily visible. … Department of Health and Human Services Office of Disease Prevention and Health Promotion … Department of Health and Human Services, Office of Disease Prevention and Health Promotion. … Promotion works to strengthen the disease prevention and health promotion activities of the U.S. … OFFICE OF DISEASE PREVENTION AND HEALTH PROMOTION DEPAR TM A U.S.

194. Section 1, Tables 1 to 3 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
     April 25, 2018 - percentile for age in the absence of external vagal stimulus, β-blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

195. Graphics for Section 7, Identification of Disparities (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-a.pdf
     November 26, 2013 -                                                     Q‐METRIC Sickle Cell Disease … Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for

196. Technical Specifications for Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-technical-specifications.pdf
     April 26, 2018 - percentile for age in the absence of external vagal stimulus, β-blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven … with chronic renal failure as defined by any mention of chronic renal failure or end stage renal disease

197. Gap Analysis for Antibiotic Stewardship Programs (doc file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/improve/gap_analysis_tool.docx
     November 01, 2019 - ☐ Yes ☐ No Is the physician leader trained in infectious disease? … ☐ Yes ☐ No Is the pharmacist leader trained in infectious diseases? … ☐ Senior executive ☐ Pharmacy department ☐ Front-line nurses ☐ Infectious diseases physicians ☐ Information … how it is compliant with The Joint Commission Antimicrobial Stewardship Standard and/or Centers for Disease … ☐ ASP members ☐ Non-AS infectious disease physicians ☐ Non-ASP pharmacists ☐ Front-line prescriber content

198. Practice Characteristic survey baseline NC Cooperative (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-nc.pdf
     November 14, 2015 - with any new approach to care Reporting measurements of practice performance on cardiovascular disease … Ischemic vascular disease Hypertension High cholesterol Diabetes Prevention services High-risk ( … Please identify how your practice uses clinical guidelines for cardiovascular disease prevention (e.g … ., use of aspirin or antithrombotics for those with ischemic vascular disease or smoking cessation … Percentage of patients aged 18 years and older with Ischemic Vascular Disease (IVD) with documented

199. Overview | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/pqmp/implementation-qi/toolkit/tcd/overview.html
     August 01, 2021 - Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. … The use of transcranial ultrasonography to predict stroke in sickle cell disease. … Evidence Based Management of Sickle Cell Disease. 2014; https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease … Cerebrovascular accidents in sickle cell disease: rates and risk factors. … Sickle cell disease and stroke.

200. More Effort Is Needed To Ensure Patients Understand Doctors' Instructions (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/dataspotlight-health-literacy.pdf
     March 01, 2019 - ◆ The National Institute on Diabetes and Digestive and Kidney Diseases encourages the use of teach-back